ODDB.org: Open Drug Database | Drugs

Pegasys 135 mcg/0,5 ml, Injektionslösung in einer Fertigspritze - 4 x 0.5 ml

Swissmedic Key	55585012	Registration Holder	CPS Cito Pharma Services GmbH
Name	Pegasys 135 mcg/0,5 ml, Injektionslösung in einer Fertigspritze	Date of registration	05.07.2001
		Introduction of Sequence	25.10.2002
ATC-Classification	Peginterferon Alfa-2a (L03AB11)	Revision date	18.12.2006
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	08.03.	Show package size	4 x 0.5 ml
Index Therapeuticus (Swissmedic)	08.03.	Description	Fertigspritzen
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	617.82	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	688.35
Feedback	FB	Daily cost
GTIN	7680555850126	Medication Code	Biotechnologika
Pharmacode	2581024	Disponibility	●

Composition

peginterferonum alfa-2a 135 µg, natrii chloridum, alcohol benzylicus 5 mg, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, natrii acetas trihydricus aut acidum aceticum ad pH, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.8 mg.

Packungsbestandteile

Galenic Form

Injektionslösung in Fertigspritze

Excipiens

Active Agent	Dose
Peginterferonum Alfa-2a	135µg / 0.5ml

BAG: Active Agent	Dose
Peginterferonum Alfa-2A	135 mcg

Inactive agents	Dose
Acidum Aceticum Glaciale
Alcohol Benzylicus	5mg / 0.5ml
Natrii Acetas Trihydricum
Natrii Acetas Trihydricus aut Acidum Aceticum ad Ph
Natrii Chloridum
Polysorbatum 80

Source

Data was imported : 06.09.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH